vs
California BanCorp \ CA（BCAL）与PROCEPT BioRobotics Corp（PRCT）财务数据对比。点击上方公司名可切换其他公司
PROCEPT BioRobotics Corp的季度营收约是California BanCorp \ CA的1.8倍（$83.1M vs $45.9M），California BanCorp \ CA净利率更高（35.8% vs -38.1%，领先73.8%），PROCEPT BioRobotics Corp同比增速更快（20.2% vs 0.8%），过去两年California BanCorp \ CA的营收复合增速更高（44.7% vs 24.8%）
太平洋第一控股是依据美国1956年银行控股公司法案成立的美国银行控股集团，总部位于加利福尼亚州欧文市。集团核心业务围绕旗下太平洋第一银行展开，为个人、企业及专业人士提供各类金融服务，目前在加州、亚利桑那州、内华达州和华盛顿州开设了多家网点。
PROCEPT BioRobotics是一家专注于研发和商业化泌尿外科手术机器人解决方案的医疗科技企业，其旗舰AquaBeam系统可为良性前列腺增生患者提供图像引导微创治疗，服务覆盖北美、欧洲等地区的医疗机构与患者。
BCAL vs PRCT — 直观对比
营收规模更大
PRCT
是对方的1.8倍
$45.9M
营收增速更快
PRCT
高出19.4%
0.8%
净利率更高
BCAL
高出73.8%
-38.1%
两年增速更快
BCAL
近两年复合增速
24.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $45.9M | $83.1M |
| 净利润 | $16.4M | $-31.6M |
| 毛利率 | — | 64.9% |
| 营业利润率 | 48.8% | -4.1% |
| 净利率 | 35.8% | -38.1% |
| 营收同比 | 0.8% | 20.2% |
| 净利润同比 | -2.1% | -27.9% |
| 每股收益（稀释后） | $0.50 | $-0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCALPRCT
| Q1 26 | — | $83.1M | ||
| Q4 25 | $45.9M | $76.4M | ||
| Q3 25 | $45.2M | $83.3M | ||
| Q2 25 | $44.3M | $79.2M | ||
| Q1 25 | $44.8M | $69.2M | ||
| Q4 24 | $45.5M | $68.2M | ||
| Q3 24 | $38.1M | $58.4M | ||
| Q2 24 | $22.2M | $53.4M |
净利润BCALPRCT
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $16.4M | $-29.8M | ||
| Q3 25 | $15.7M | $-21.4M | ||
| Q2 25 | $14.1M | $-19.6M | ||
| Q1 25 | $16.9M | $-24.7M | ||
| Q4 24 | $16.8M | $-18.9M | ||
| Q3 24 | $-16.5M | $-21.0M | ||
| Q2 24 | $190.0K | $-25.6M |
毛利率BCALPRCT
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
营业利润率BCALPRCT
| Q1 26 | — | -4.1% | ||
| Q4 25 | 48.8% | -40.6% | ||
| Q3 25 | 48.3% | -27.8% | ||
| Q2 25 | 45.3% | -28.0% | ||
| Q1 25 | 52.8% | -39.7% | ||
| Q4 24 | 52.2% | -28.9% | ||
| Q3 24 | -59.1% | -38.4% | ||
| Q2 24 | 1.3% | -50.3% |
净利率BCALPRCT
| Q1 26 | — | -38.1% | ||
| Q4 25 | 35.8% | -39.1% | ||
| Q3 25 | 34.7% | -25.7% | ||
| Q2 25 | 31.8% | -24.7% | ||
| Q1 25 | 37.6% | -35.8% | ||
| Q4 24 | 37.7% | -27.6% | ||
| Q3 24 | -43.2% | -35.9% | ||
| Q2 24 | 0.9% | -48.0% |
每股收益（稀释后）BCALPRCT
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.50 | $-0.54 | ||
| Q3 25 | $0.48 | $-0.38 | ||
| Q2 25 | $0.43 | $-0.35 | ||
| Q1 25 | $0.52 | $-0.45 | ||
| Q4 24 | $0.54 | $-0.34 | ||
| Q3 24 | $-0.59 | $-0.40 | ||
| Q2 24 | $0.01 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $399.9M | $245.6M |
| 总债务越低越好 | $33.8M | $51.7M |
| 股东权益账面价值 | $576.6M | $347.7M |
| 总资产 | $4.0B | $487.1M |
| 负债/权益比越低杠杆越低 | 0.06× | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资BCALPRCT
| Q1 26 | — | $245.6M | ||
| Q4 25 | $399.9M | $286.5M | ||
| Q3 25 | $559.2M | $294.3M | ||
| Q2 25 | $430.1M | $302.7M | ||
| Q1 25 | $439.2M | $316.2M | ||
| Q4 24 | $388.2M | $333.7M | ||
| Q3 24 | $614.4M | $196.8M | ||
| Q2 24 | $104.7M | $214.1M |
总债务BCALPRCT
| Q1 26 | — | $51.7M | ||
| Q4 25 | $33.8M | $51.6M | ||
| Q3 25 | $33.4M | $51.6M | ||
| Q2 25 | $52.9M | $51.5M | ||
| Q1 25 | $70.3M | $51.5M | ||
| Q4 24 | $69.7M | $51.5M | ||
| Q3 24 | $69.1M | $51.4M | ||
| Q2 24 | $42.9M | $51.4M |
股东权益BCALPRCT
| Q1 26 | — | $347.7M | ||
| Q4 25 | $576.6M | $365.9M | ||
| Q3 25 | $564.7M | $380.3M | ||
| Q2 25 | $547.6M | $385.8M | ||
| Q1 25 | $531.4M | $389.2M | ||
| Q4 24 | $511.8M | $402.2M | ||
| Q3 24 | $498.1M | $241.2M | ||
| Q2 24 | $293.2M | $251.8M |
总资产BCALPRCT
| Q1 26 | — | $487.1M | ||
| Q4 25 | $4.0B | $508.1M | ||
| Q3 25 | $4.1B | $511.5M | ||
| Q2 25 | $4.0B | $513.1M | ||
| Q1 25 | $4.0B | $519.4M | ||
| Q4 24 | $4.0B | $534.0M | ||
| Q3 24 | $4.4B | $374.1M | ||
| Q2 24 | $2.3B | $374.4M |
负债/权益比BCALPRCT
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.06× | 0.14× | ||
| Q3 25 | 0.06× | 0.14× | ||
| Q2 25 | 0.10× | 0.13× | ||
| Q1 25 | 0.13× | 0.13× | ||
| Q4 24 | 0.14× | 0.13× | ||
| Q3 24 | 0.14× | 0.21× | ||
| Q2 24 | 0.15× | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.3M | — |
| 自由现金流经营现金流 - 资本支出 | $56.9M | — |
| 自由现金流率自由现金流/营收 | 124.1% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | 3.49× | — |
| 过去12个月自由现金流最近4个季度 | $93.1M | — |
8季度趋势，按日历期对齐
经营现金流BCALPRCT
| Q1 26 | — | — | ||
| Q4 25 | $57.3M | $-10.3M | ||
| Q3 25 | $16.0M | $-6.6M | ||
| Q2 25 | $13.4M | $-15.0M | ||
| Q1 25 | $7.0M | $-17.0M | ||
| Q4 24 | $50.3M | $-32.4M | ||
| Q3 24 | $18.3M | $-18.8M | ||
| Q2 24 | $309.0K | $-15.7M |
自由现金流BCALPRCT
| Q1 26 | — | — | ||
| Q4 25 | $56.9M | $-12.2M | ||
| Q3 25 | $15.9M | $-9.5M | ||
| Q2 25 | $13.4M | $-17.8M | ||
| Q1 25 | $6.9M | $-18.8M | ||
| Q4 24 | $49.7M | $-33.6M | ||
| Q3 24 | $18.1M | $-19.0M | ||
| Q2 24 | $171.0K | $-16.8M |
自由现金流率BCALPRCT
| Q1 26 | — | — | ||
| Q4 25 | 124.1% | -15.9% | ||
| Q3 25 | 35.1% | -11.4% | ||
| Q2 25 | 30.2% | -22.5% | ||
| Q1 25 | 15.3% | -27.2% | ||
| Q4 24 | 109.2% | -49.2% | ||
| Q3 24 | 47.5% | -32.6% | ||
| Q2 24 | 0.8% | -31.4% |
资本支出强度BCALPRCT
| Q1 26 | — | — | ||
| Q4 25 | 0.8% | 2.4% | ||
| Q3 25 | 0.2% | 3.4% | ||
| Q2 25 | 0.1% | 3.5% | ||
| Q1 25 | 0.2% | 2.7% | ||
| Q4 24 | 1.2% | 1.7% | ||
| Q3 24 | 0.5% | 0.4% | ||
| Q2 24 | 0.6% | 2.0% |
现金转化率BCALPRCT
| Q1 26 | — | — | ||
| Q4 25 | 3.49× | — | ||
| Q3 25 | 1.02× | — | ||
| Q2 25 | 0.95× | — | ||
| Q1 25 | 0.41× | — | ||
| Q4 24 | 3.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.63× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCAL
暂无分部数据
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
